Joseph M. Scavone

Dr. Joseph M. Scavone is experienced in the areas of clinical drug development, clinical pharmacology, and safety and risk management. He worked at Pfizer for 24 years and held positions as a Clinical Group Lead in the Neurosciences, Pain and Rare Diseases therapeutic areas in the Clinical Development and Operations group, as a Global Clinical Lead for pregabalin (Lyrica) and as a Therapeutic Area Head and Group Lead in the Worldwide Regulatory Affairs/Safety and Risk Management group. Joe has had many years of experience in designing, conducting, and managing Phase 1-4 clinical studies, managing drug development programs, and writing and reviewing regulatory submission documents. He has worked on several NDAs and MAAs that have resulted in global regulatory approvals. Joe has published over 100 original peer-reviewed research articles, abstracts, book chapters and a book on conducting clinical studies. He has appointments as an adjunct Associate Professor at Temple University School of Pharmacy, RA/QA Program, where he teaches courses about Clinical Trials Management and Good Clinical Practices, and as an Assistant Clinical Professor at Tufts University School of Medicine.